The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preimplantation Genetic Diagnosis Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Preimplantation Genetic Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Preimplantation Genetic Diagnosis market size is estimated to be worth US$ 104.6 million in 2021 and is forecast to a readjusted size of USD 138.6 million by 2028 with a CAGR of 4.1% during review period. Fertility Clinics accounting for % of the Preimplantation Genetic Diagnosis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Genetic Diagnosis segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Preimplantation Genetic Diagnosis include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., and Coopersurgical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Preimplantation Genetic Diagnosis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Genetic Diagnosis
Genetic Screening
Market segment by Application, can be divided into
Fertility Clinics
Research
Market segment by players, this report covers
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Coopersurgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Preimplantation Genetic Diagnosis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Preimplantation Genetic Diagnosis, with revenue, gross margin and global market share of Preimplantation Genetic Diagnosis from 2019 to 2022.
Chapter 3, the Preimplantation Genetic Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Preimplantation Genetic Diagnosis market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Preimplantation Genetic Diagnosis research findings and conclusion, appendix and data source.
Geographical Area
Global
The Preimplantation Genetic Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Preimplantation Genetic Diagnosis market size is estimated to be worth US$ 104.6 million in 2021 and is forecast to a readjusted size of USD 138.6 million by 2028 with a CAGR of 4.1% during review period. Fertility Clinics accounting for % of the Preimplantation Genetic Diagnosis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Genetic Diagnosis segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Preimplantation Genetic Diagnosis include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., and Coopersurgical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Preimplantation Genetic Diagnosis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Genetic Diagnosis
Genetic Screening
Market segment by Application, can be divided into
Fertility Clinics
Research
Market segment by players, this report covers
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Coopersurgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Preimplantation Genetic Diagnosis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Preimplantation Genetic Diagnosis, with revenue, gross margin and global market share of Preimplantation Genetic Diagnosis from 2019 to 2022.
Chapter 3, the Preimplantation Genetic Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Preimplantation Genetic Diagnosis market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Preimplantation Genetic Diagnosis research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Preimplantation Genetic Diagnosis
1.2 Classification of Preimplantation Genetic Diagnosis by Type
1.2.1 Overview: Global Preimplantation Genetic Diagnosis Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Preimplantation Genetic Diagnosis Revenue Market Share by Type in 2021
1.2.3 Genetic Diagnosis
1.2.4 Genetic Screening
1.3 Global Preimplantation Genetic Diagnosis Market by Application
1.3.1 Overview: Global Preimplantation Genetic Diagnosis Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Fertility Clinics
1.3.3 Research
1.4 Global Preimplantation Genetic Diagnosis Market Size & Forecast
1.5 Global Preimplantation Genetic Diagnosis Market Size and Forecast by Region
1.5.1 Global Preimplantation Genetic Diagnosis Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Preimplantation Genetic Diagnosis Market Size by Region, (2017-2022)
1.5.3 North America Preimplantation Genetic Diagnosis Market Size and Prospect (2017-2028)
1.5.4 Europe Preimplantation Genetic Diagnosis Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Preimplantation Genetic Diagnosis Market Size and Prospect (2017-2028)
1.5.6 South America Preimplantation Genetic Diagnosis Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Preimplantation Genetic Diagnosis Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Preimplantation Genetic Diagnosis Market Drivers
1.6.2 Preimplantation Genetic Diagnosis Market Restraints
1.6.3 Preimplantation Genetic Diagnosis Trends Analysis
2 Company Profiles
2.1 Illumina, Inc.
2.1.1 Illumina, Inc. Details
2.1.2 Illumina, Inc. Major Business
2.1.3 Illumina, Inc. Preimplantation Genetic Diagnosis Product and Solutions
2.1.4 Illumina, Inc. Preimplantation Genetic Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Illumina, Inc. Recent Developments and Future Plans
2.2 Thermo Fisher Scientific Inc.
2.2.1 Thermo Fisher Scientific Inc. Details
2.2.2 Thermo Fisher Scientific Inc. Major Business
2.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnosis Product and Solutions
2.2.4 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.3 Agilent Technologies, Inc.
2.3.1 Agilent Technologies, Inc. Details
2.3.2 Agilent Technologies, Inc. Major Business
2.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnosis Product and Solutions
2.3.4 Agilent Technologies, Inc. Preimplantation Genetic Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.4 Perkinelmer, Inc.
2.4.1 Perkinelmer, Inc. Details
2.4.2 Perkinelmer, Inc. Major Business
2.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnosis Product and Solutions
2.4.4 Perkinelmer, Inc. Preimplantation Genetic Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Perkinelmer, Inc. Recent Developments and Future Plans
2.5 Coopersurgical
2.5.1 Coopersurgical Details
2.5.2 Coopersurgical Major Business
2.5.3 Coopersurgical Preimplantation Genetic Diagnosis Product and Solutions
2.5.4 Coopersurgical Preimplantation Genetic Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Coopersurgical Recent Developments and Future Plans
2.6 ABBott Laboratories
2.6.1 ABBott Laboratories Details
2.6.2 ABBott Laboratories Major Business
2.6.3 ABBott Laboratories Preimplantation Genetic Diagnosis Product and Solutions
2.6.4 ABBott Laboratories Preimplantation Genetic Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 ABBott Laboratories Recent Developments and Future Plans
2.7 Natera, Inc.
2.7.1 Natera, Inc. Details
2.7.2 Natera, Inc. Major Business
2.7.3 Natera, Inc. Preimplantation Genetic Diagnosis Product and Solutions
2.7.4 Natera, Inc. Preimplantation Genetic Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Natera, Inc. Recent Developments and Future Plans
2.8 Rubicon Genomics
2.8.1 Rubicon Genomics Details
2.8.2 Rubicon Genomics Major Business
2.8.3 Rubicon Genomics Preimplantation Genetic Diagnosis Product and Solutions
2.8.4 Rubicon Genomics Preimplantation Genetic Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Rubicon Genomics Recent Developments and Future Plans
2.9 Oxford Gene Technology
2.9.1 Oxford Gene Technology Details
2.9.2 Oxford Gene Technology Major Business
2.9.3 Oxford Gene Technology Preimplantation Genetic Diagnosis Product and Solutions
2.9.4 Oxford Gene Technology Preimplantation Genetic Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Oxford Gene Technology Recent Developments and Future Plans
2.10 Yikon Genomics
2.10.1 Yikon Genomics Details
2.10.2 Yikon Genomics Major Business
2.10.3 Yikon Genomics Preimplantation Genetic Diagnosis Product and Solutions
2.10.4 Yikon Genomics Preimplantation Genetic Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Yikon Genomics Recent Developments and Future Plans
2.11 Scigene
2.11.1 Scigene Details
2.11.2 Scigene Major Business
2.11.3 Scigene Preimplantation Genetic Diagnosis Product and Solutions
2.11.4 Scigene Preimplantation Genetic Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Scigene Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Preimplantation Genetic Diagnosis Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Preimplantation Genetic Diagnosis Players Market Share in 2021
3.2.2 Top 10 Preimplantation Genetic Diagnosis Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Preimplantation Genetic Diagnosis Players Head Office, Products and Services Provided
3.4 Preimplantation Genetic Diagnosis Mergers & Acquisitions
3.5 Preimplantation Genetic Diagnosis New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Preimplantation Genetic Diagnosis Revenue and Market Share by Type (2017-2022)
4.2 Global Preimplantation Genetic Diagnosis Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Preimplantation Genetic Diagnosis Revenue Market Share by Application (2017-2022)
5.2 Global Preimplantation Genetic Diagnosis Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Preimplantation Genetic Diagnosis Revenue by Type (2017-2028)
6.2 North America Preimplantation Genetic Diagnosis Revenue by Application (2017-2028)
6.3 North America Preimplantation Genetic Diagnosis Market Size by Country
6.3.1 North America Preimplantation Genetic Diagnosis Revenue by Country (2017-2028)
6.3.2 United States Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
6.3.3 Canada Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
6.3.4 Mexico Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Preimplantation Genetic Diagnosis Revenue by Type (2017-2028)
7.2 Europe Preimplantation Genetic Diagnosis Revenue by Application (2017-2028)
7.3 Europe Preimplantation Genetic Diagnosis Market Size by Country
7.3.1 Europe Preimplantation Genetic Diagnosis Revenue by Country (2017-2028)
7.3.2 Germany Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
7.3.3 France Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
7.3.5 Russia Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
7.3.6 Italy Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Preimplantation Genetic Diagnosis Revenue by Type (2017-2028)
8.2 Asia-Pacific Preimplantation Genetic Diagnosis Revenue by Application (2017-2028)
8.3 Asia-Pacific Preimplantation Genetic Diagnosis Market Size by Region
8.3.1 Asia-Pacific Preimplantation Genetic Diagnosis Revenue by Region (2017-2028)
8.3.2 China Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
8.3.3 Japan Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
8.3.4 South Korea Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
8.3.5 India Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
8.3.7 Australia Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Preimplantation Genetic Diagnosis Revenue by Type (2017-2028)
9.2 South America Preimplantation Genetic Diagnosis Revenue by Application (2017-2028)
9.3 South America Preimplantation Genetic Diagnosis Market Size by Country
9.3.1 South America Preimplantation Genetic Diagnosis Revenue by Country (2017-2028)
9.3.2 Brazil Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
9.3.3 Argentina Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Preimplantation Genetic Diagnosis Revenue by Type (2017-2028)
10.2 Middle East & Africa Preimplantation Genetic Diagnosis Revenue by Application (2017-2028)
10.3 Middle East & Africa Preimplantation Genetic Diagnosis Market Size by Country
10.3.1 Middle East & Africa Preimplantation Genetic Diagnosis Revenue by Country (2017-2028)
10.3.2 Turkey Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
10.3.4 UAE Preimplantation Genetic Diagnosis Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Preimplantation Genetic Diagnosis Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Preimplantation Genetic Diagnosis Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Preimplantation Genetic Diagnosis Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Preimplantation Genetic Diagnosis Revenue (USD Million) by Region (2017-2022)
Table 5. Global Preimplantation Genetic Diagnosis Revenue Market Share by Region (2023-2028)
Table 6. Illumina, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Illumina, Inc. Major Business
Table 8. Illumina, Inc. Preimplantation Genetic Diagnosis Product and Solutions
Table 9. Illumina, Inc. Preimplantation Genetic Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Inc. Major Business
Table 12. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnosis Product and Solutions
Table 13. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Agilent Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Agilent Technologies, Inc. Major Business
Table 16. Agilent Technologies, Inc. Preimplantation Genetic Diagnosis Product and Solutions
Table 17. Agilent Technologies, Inc. Preimplantation Genetic Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Perkinelmer, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Perkinelmer, Inc. Major Business
Table 20. Perkinelmer, Inc. Preimplantation Genetic Diagnosis Product and Solutions
Table 21. Perkinelmer, Inc. Preimplantation Genetic Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Coopersurgical Corporate Information, Head Office, and Major Competitors
Table 23. Coopersurgical Major Business
Table 24. Coopersurgical Preimplantation Genetic Diagnosis Product and Solutions
Table 25. Coopersurgical Preimplantation Genetic Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. ABBott Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. ABBott Laboratories Major Business
Table 28. ABBott Laboratories Preimplantation Genetic Diagnosis Product and Solutions
Table 29. ABBott Laboratories Preimplantation Genetic Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Natera, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Natera, Inc. Major Business
Table 32. Natera, Inc. Preimplantation Genetic Diagnosis Product and Solutions
Table 33. Natera, Inc. Preimplantation Genetic Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Rubicon Genomics Corporate Information, Head Office, and Major Competitors
Table 35. Rubicon Genomics Major Business
Table 36. Rubicon Genomics Preimplantation Genetic Diagnosis Product and Solutions
Table 37. Rubicon Genomics Preimplantation Genetic Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Oxford Gene Technology Corporate Information, Head Office, and Major Competitors
Table 39. Oxford Gene Technology Major Business
Table 40. Oxford Gene Technology Preimplantation Genetic Diagnosis Product and Solutions
Table 41. Oxford Gene Technology Preimplantation Genetic Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Yikon Genomics Corporate Information, Head Office, and Major Competitors
Table 43. Yikon Genomics Major Business
Table 44. Yikon Genomics Preimplantation Genetic Diagnosis Product and Solutions
Table 45. Yikon Genomics Preimplantation Genetic Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Scigene Corporate Information, Head Office, and Major Competitors
Table 47. Scigene Major Business
Table 48. Scigene Preimplantation Genetic Diagnosis Product and Solutions
Table 49. Scigene Preimplantation Genetic Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Global Preimplantation Genetic Diagnosis Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 51. Global Preimplantation Genetic Diagnosis Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 52. Breakdown of Preimplantation Genetic Diagnosis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Preimplantation Genetic Diagnosis Players Head Office, Products and Services Provided
Table 54. Preimplantation Genetic Diagnosis Mergers & Acquisitions in the Past Five Years
Table 55. Preimplantation Genetic Diagnosis New Entrants and Expansion Plans
Table 56. Global Preimplantation Genetic Diagnosis Revenue (USD Million) by Type (2017-2022)
Table 57. Global Preimplantation Genetic Diagnosis Revenue Share by Type (2017-2022)
Table 58. Global Preimplantation Genetic Diagnosis Revenue Forecast by Type (2023-2028)
Table 59. Global Preimplantation Genetic Diagnosis Revenue by Application (2017-2022)
Table 60. Global Preimplantation Genetic Diagnosis Revenue Forecast by Application (2023-2028)
Table 61. North America Preimplantation Genetic Diagnosis Revenue by Type (2017-2022) & (USD Million)
Table 62. North America Preimplantation Genetic Diagnosis Revenue by Type (2023-2028) & (USD Million)
Table 63. North America Preimplantation Genetic Diagnosis Revenue by Application (2017-2022) & (USD Million)
Table 64. North America Preimplantation Genetic Diagnosis Revenue by Application (2023-2028) & (USD Million)
Table 65. North America Preimplantation Genetic Diagnosis Revenue by Country (2017-2022) & (USD Million)
Table 66. North America Preimplantation Genetic Diagnosis Revenue by Country (2023-2028) & (USD Million)
Table 67. Europe Preimplantation Genetic Diagnosis Revenue by Type (2017-2022) & (USD Million)
Table 68. Europe Preimplantation Genetic Diagnosis Revenue by Type (2023-2028) & (USD Million)
Table 69. Europe Preimplantation Genetic Diagnosis Revenue by Application (2017-2022) & (USD Million)
Table 70. Europe Preimplantation Genetic Diagnosis Revenue by Application (2023-2028) & (USD Million)
Table 71. Europe Preimplantation Genetic Diagnosis Revenue by Country (2017-2022) & (USD Million)
Table 72. Europe Preimplantation Genetic Diagnosis Revenue by Country (2023-2028) & (USD Million)
Table 73. Asia-Pacific Preimplantation Genetic Diagnosis Revenue by Type (2017-2022) & (USD Million)
Table 74. Asia-Pacific Preimplantation Genetic Diagnosis Revenue by Type (2023-2028) & (USD Million)
Table 75. Asia-Pacific Preimplantation Genetic Diagnosis Revenue by Application (2017-2022) & (USD Million)
Table 76. Asia-Pacific Preimplantation Genetic Diagnosis Revenue by Application (2023-2028) & (USD Million)
Table 77. Asia-Pacific Preimplantation Genetic Diagnosis Revenue by Region (2017-2022) & (USD Million)
Table 78. Asia-Pacific Preimplantation Genetic Diagnosis Revenue by Region (2023-2028) & (USD Million)
Table 79. South America Preimplantation Genetic Diagnosis Revenue by Type (2017-2022) & (USD Million)
Table 80. South America Preimplantation Genetic Diagnosis Revenue by Type (2023-2028) & (USD Million)
Table 81. South America Preimplantation Genetic Diagnosis Revenue by Application (2017-2022) & (USD Million)
Table 82. South America Preimplantation Genetic Diagnosis Revenue by Application (2023-2028) & (USD Million)
Table 83. South America Preimplantation Genetic Diagnosis Revenue by Country (2017-2022) & (USD Million)
Table 84. South America Preimplantation Genetic Diagnosis Revenue by Country (2023-2028) & (USD Million)
Table 85. Middle East & Africa Preimplantation Genetic Diagnosis Revenue by Type (2017-2022) & (USD Million)
Table 86. Middle East & Africa Preimplantation Genetic Diagnosis Revenue by Type (2023-2028) & (USD Million)
Table 87. Middle East & Africa Preimplantation Genetic Diagnosis Revenue by Application (2017-2022) & (USD Million)
Table 88. Middle East & Africa Preimplantation Genetic Diagnosis Revenue by Application (2023-2028) & (USD Million)
Table 89. Middle East & Africa Preimplantation Genetic Diagnosis Revenue by Country (2017-2022) & (USD Million)
Table 90. Middle East & Africa Preimplantation Genetic Diagnosis Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Preimplantation Genetic Diagnosis Picture
Figure 2. Global Preimplantation Genetic Diagnosis Revenue Market Share by Type in 2021
Figure 3. Genetic Diagnosis
Figure 4. Genetic Screening
Figure 5. Preimplantation Genetic Diagnosis Revenue Market Share by Application in 2021
Figure 6. Fertility Clinics Picture
Figure 7. Research Picture
Figure 8. Global Preimplantation Genetic Diagnosis Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Preimplantation Genetic Diagnosis Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Preimplantation Genetic Diagnosis Revenue Market Share by Region (2017-2028)
Figure 11. Global Preimplantation Genetic Diagnosis Revenue Market Share by Region in 2021
Figure 12. North America Preimplantation Genetic Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Preimplantation Genetic Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Preimplantation Genetic Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Preimplantation Genetic Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Preimplantation Genetic Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Preimplantation Genetic Diagnosis Market Drivers
Figure 18. Preimplantation Genetic Diagnosis Market Restraints
Figure 19. Preimplantation Genetic Diagnosis Market Trends
Figure 20. Illumina, Inc. Recent Developments and Future Plans
Figure 21. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Figure 22. Agilent Technologies, Inc. Recent Developments and Future Plans
Figure 23. Perkinelmer, Inc. Recent Developments and Future Plans
Figure 24. Coopersurgical Recent Developments and Future Plans
Figure 25. ABBott Laboratories Recent Developments and Future Plans
Figure 26. Natera, Inc. Recent Developments and Future Plans
Figure 27. Rubicon Genomics Recent Developments and Future Plans
Figure 28. Oxford Gene Technology Recent Developments and Future Plans
Figure 29. Yikon Genomics Recent Developments and Future Plans
Figure 30. Scigene Recent Developments and Future Plans
Figure 31. Global Preimplantation Genetic Diagnosis Revenue Share by Players in 2021
Figure 32. Preimplantation Genetic Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 33. Global Top 3 Players Preimplantation Genetic Diagnosis Revenue Market Share in 2021
Figure 34. Global Top 10 Players Preimplantation Genetic Diagnosis Revenue Market Share in 2021
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 36. Global Preimplantation Genetic Diagnosis Revenue Share by Type in 2021
Figure 37. Global Preimplantation Genetic Diagnosis Market Share Forecast by Type (2023-2028)
Figure 38. Global Preimplantation Genetic Diagnosis Revenue Share by Application in 2021
Figure 39. Global Preimplantation Genetic Diagnosis Market Share Forecast by Application (2023-2028)
Figure 40. North America Preimplantation Genetic Diagnosis Sales Market Share by Type (2017-2028)
Figure 41. North America Preimplantation Genetic Diagnosis Sales Market Share by Application (2017-2028)
Figure 42. North America Preimplantation Genetic Diagnosis Revenue Market Share by Country (2017-2028)
Figure 43. United States Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Preimplantation Genetic Diagnosis Sales Market Share by Type (2017-2028)
Figure 47. Europe Preimplantation Genetic Diagnosis Sales Market Share by Application (2017-2028)
Figure 48. Europe Preimplantation Genetic Diagnosis Revenue Market Share by Country (2017-2028)
Figure 49. Germany Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Preimplantation Genetic Diagnosis Sales Market Share by Type (2017-2028)
Figure 55. Asia-Pacific Preimplantation Genetic Diagnosis Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Preimplantation Genetic Diagnosis Revenue Market Share by Region (2017-2028)
Figure 57. China Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. South Korea Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Preimplantation Genetic Diagnosis Sales Market Share by Type (2017-2028)
Figure 64. South America Preimplantation Genetic Diagnosis Sales Market Share by Application (2017-2028)
Figure 65. South America Preimplantation Genetic Diagnosis Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East and Africa Preimplantation Genetic Diagnosis Sales Market Share by Type (2017-2028)
Figure 69. Middle East and Africa Preimplantation Genetic Diagnosis Sales Market Share by Application (2017-2028)
Figure 70. Middle East and Africa Preimplantation Genetic Diagnosis Revenue Market Share by Country (2017-2028)
Figure 71. Turkey Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Saudi Arabia Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. UAE Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
